Cargando…
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
Coronavirus disease 2019 (COVID-19) convalescent plasma (CovCP) infusions have been widely used for the treatment of hospitalized patients with COVID-19. The aims of this narrative review were to analyze the safety and efficacy of CovCP infusions in the overall population and in immunocompromised pa...
Autores principales: | Beraud, Mickael, Goodhue Meyer, Erin, Lozano, Miquel, Bah, Aicha, Vassallo, Ralph, Brown, Bethany L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757642/ https://www.ncbi.nlm.nih.gov/pubmed/35063360 http://dx.doi.org/10.1016/j.transci.2022.103355 |
Ejemplares similares
-
Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome
por: Beraud, Mickael, et al.
Publicado: (2022) -
Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021) -
Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
por: Rodionov, Roman N, et al.
Publicado: (2021) -
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023) -
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
por: Franchini, Massimo, et al.
Publicado: (2023)